All posts by student

College of Medicine graduate student launches genetics research startup – Penn State News

HERSHEY, Pa. Olivier Noel is only 28 years old, but hes already changing the face of genetics research.

The Haitian native is in his sixth year of Penn State College of MedicinesMD/PhD Medical Scientist Training Programand was recently recognized by Forbes as one of the countrys brightest young entrepreneurs on its30 Under 30 list in the science industry. Hes the founder of DNAsimple, a startup aimed at accelerating genetics research by connecting DNA donors with research scientists. The company provides scientists with access to critically important samples, significantly speeding up the pace for genetics research.

People dont realize it can take years to get samples, but really only a month to get an assignment done which is a little bit ridiculous, Noel said. Its a problem for geneticists across the board. You can have a million dollars to do a study, but waste three years trying to get samples.

Noel explained a light bulb went off when he attended a genetics conference at the recommendation of Dr. Roger L. Ladda, whom he had been shadowing with the intent of focusing his residency on genetics.

The keynote speaker at the conference was talking about how he was studying a disease not really prevalent in the Western world, and the way they were able to get a DNA sample to validate was through Facebook. The joke at the time was that Facebook is the new way of doing genetics. I realized, wow, that worked well for one case but thats not the way science should get done, Noel said.

Noels big break was when the company was accepted into the Y Combinator program, which includes such notable alumni as Dropbox, Airbnb and Reddit. DNAsimple was one of 32 companies accepted from more than 6,500 applicants worldwide, he said. But he credits his doctoral advisors former Penn State faculty member Dr. Glenn S. Gerhard and Penn State College of Medicine Chair of Biochemistry and Molecular BiologyJames Broach for teaching him about genetics and exposing him to the Penn State Institute for Personalized Medicine.

Learn more about Noel and his work in this Penn State Medicine article.

Last Updated February 14, 2017

Read the original post:
College of Medicine graduate student launches genetics research startup - Penn State News

Athletigen, Kinduct Technologies To Integrate Genetics With Athletic Performance Insights – SportTechie

Sports genetics company Athletigen Technologies is teaming up with Kinduct Technologies, a data and analytics software provider, to integrate genetics with athletic performance data.

Athletigen is known for analyzing an athletes genetic makeup and using that to help the athlete achieve his or her performance goals. Kinduct allows teams and organizations to look at data from multiple athletes and use that to make informed decisions to improve individual performance.

The partnership with Kinduct is an exciting opportunity, with both companies focused on pushing the limits of human performance, Athletigen CEO Dr. Jeremy Koenig said in a statement Tuesday. Clients will now have access to genetic markers combined with performance data, biometric scores and subjective inputs to provide a comprehensive view of the athlete to help understand and improve their in-game performance.

Get The Latest Sports Tech News In Your Inbox!

Before teaming up with Athletigen, Kinducts products collected and analyzed data for a wide range of athletes. Now, there will be an added layer of genetics data.

For Athletigen, this partnership could be a way to expand the brand. Kinduct has established relationships inthe NHL, MLB, NFL, NBA, MLS and NCAA, and now, Athletigens insights in geneticscan reach teams in those leagues as well.

Read more from the original source:
Athletigen, Kinduct Technologies To Integrate Genetics With Athletic Performance Insights - SportTechie

Mutant Maize Offers Key to Understanding Plant Growth – UCR Today (press release)

Live cell time-lapse imaging of maize mutant provides crucial details for UC Riverside researchers

By Sean Nealon on February 13, 2017

From left, normal and mutant maize plants.

RIVERSIDE, Calif. (www.ucr.edu) How plant cells divide and how that contributes to plant growth has been one of the longstanding unsolved mysteries of cell biology. Two conflicting ideas have fueled the mystery.

The first idea is that cells divide merely to fill space in plant tissue, and therefore the orientation of the division is unimportant to growth. In other words, the contribution of individual cell behavior to overall growth isnt very important.

The second idea is that individual cells are the basic unit of life and their individual programs eventually build an organism. In other words, each new cell created contributes to proper patterning of the tissue. In this case, the orientation of each cells division is critical for how the plant tissue is patterned and also impacts growth.

New findings by a University of California, Riverside-led team of researchers, lend support to the second idea, that the orientation of cell division is critical for overall plant growth. The work was just published in the journal Proceedings of the National Academy of Sciences.

The researchers, led by Carolyn Rasmussen, an assistant professor of plant cell biology at UC Riverside and Pablo Martinez, a graduate student working in Rasmussens lab, together with Anding Luo and Anne Sylvester at University of Wyoming, were working with a maize mutant, called tangled1, with known defects in growth and division plane orientation of cells. Division plane orientation refers to the positioning of new cell walls during division.

Scanning electron micrographs of maize epidermal cells. Left is the mutant variety. Right is the wild variety.

They used time-lapse live cell imaging that represented hundreds of hours of maize, (commonly called corn in the United States), cells dividing. The time-lapse of imaging allowed them to characterize a previously unknown delay during cell division stages in the maize mutant. This study clarified the relationship between growth, timely division progression and proper division plane orientation.

This study suggests that delays during division do not necessarily cause growth defects, but that improper placement of new cell walls together with delays during division causes growth defects. Therefore, division plane orientation is a critical but potentially indirect factor for growth.

The findings might have long-term implications for increasing agricultural production. For example, during the Green Revolution of the mid-20th century, researchers developed short-stature, or dwarf, wheat and rice varieties that led to higher yields and are credited with saving over a billion people from starvation. Understanding the molecular mechanisms of plant growth might contribute in the long-term to developing more suitable short-stature maize varieties.

The paper is called Proper division plane orientation and mitotic progression together allow normal growth of maize.

Archived under: Science/Technology, Carolyn Rasmussen, College of Natural and Agricultural Sciences, Department of Botany and Plant Sciences, Pablo Martinez, press release

Top of Page

View original post here:
Mutant Maize Offers Key to Understanding Plant Growth - UCR Today (press release)

Anatomy class teaches several lessons – Seguin Gazette: Editorials – Seguin Gazette-Enterprise

Recently, a group of high school students, under the direction of anatomy teacher Daniel Sanchez visited Vogel Elementary and taught all of the second grade students a little lesson.

The subject a human cell.

While this may seem a little outside the younger students realm of understanding, the teens delivered the lesson in a way the youngsters could understand.

Prior to the visit, Sanchez, wanted to make sure his students understood the lesson and tasked them with writing a childrens story.

By using the terminology and definitions, his students received an easier way to remember what they have learned.

What he didnt expect to happen was to see that lesson evolve beyond his classroom, and spill over into the elementary classroom.

As Sanchez students read their stories to the second graders, the children eagerly listened and then asked questions.

They also got to see what a human cell looks like thanks to the models the teens also created for their class, unknowing that it would become a prop for this special session.

Not only did the high school students learn, but they taught their younger counterparts, solidifying what they learned.

They became role models for the younger students, and helped them engage in conversations.

They created a new curiosity for science, and quite possibly an interest that can lead to things beyond what they imagined.

Our Voice is the opinion of the Seguin Gazette editorial board.

Continue reading here:
Anatomy class teaches several lessons - Seguin Gazette: Editorials - Seguin Gazette-Enterprise

Anatomy of a heart attack – goskagit.com

HEART ATTACKS HAPPEN to both women and menbut they dont always look the same. Theyre not as obvious as youd see on TV, and thats true for more women than men.

Heres a look at what makes recognizing a heart attack so importantand why noticing more subtle signs is especially important for women.

What to look for

What does a heart attack feel like? Chest pain or discomfort is the most common symptom for both women and men. The pain may last a few minutes or come and go. Some people say it feels like pressure, squeezing, or fullness. Or it may feel like an upset stomach or heartburn.

But women are more likely than men to have other heart attack signs, says Paul Connor, MD, PeaceHealth Medical Group Cardiology, in Bellingham.

Those may include:

Shortness of breath with or without chest pain

Nausea, lightheadedness, or vomiting

Unexplained fatigue that may last for days

Back, shoulder, arm or jaw pain

Women are also at higher risk for silent heart attacks, according to some studies. This is when symptoms of a heart attack are so mild that they go unnoticedor are dismissed as anxiety.

Silent heart attacks are just as dangerous as more obvious heart attacks, though, says Dr. Connor. Left untreated, they can cause scarring and permanent damage, raising the risk of other heart problems.

So dont be too quick to dismiss shortness of breath or lightheadedness as just anxiety. And make sure you tell medical professionals that you think youre having a heart attack, not an anxiety attack.

A supply problem at the pump

Despite womens more subtle symptoms, the mechanics of a heart attack are fundamentally the same for both sexes. It happens when the hearts blood supply is reduced or cut off, most often when an artery becomes blocked.

What usually sets the stage? Doctors call it atherosclerosis. It happens when arteries that bring blood to the heart slowly become clogged with plaque. A blood clot can form around these plaques, causing complete obstruction of the blood flow to the heart muscle.

Without prompt treatment, areas of heart muscle may die and eventually be replaced by scars. This damage could leave a heart attack survivor with a weakened heart.

And a weak heart may not be able to pump blood to the bodys organs like it should, which could result in other quality-of-life issues, Dr. Connor says.

Quick treatment can restore blood flow to the heart and help prevent damage. So be aware of these warning signs for both yourself and others. If theres even a slight chance you could be having a heart attack, dont wait. Call 911 and get to a hospital to give your heart the best chance.

See more here:
Anatomy of a heart attack - goskagit.com

Seattle Genetics Earnings: Waiting on ECHELON – Motley Fool

2017 is looking like a transition year for the biotech.

Seattle Genetics (NASDAQ:SGEN) released fourth-quarter earnings on Thursday and gave investors a taste of what's to come later this year. With modest growth for Adcetris, its only drug on the market, investors should be focused on Seattle Genetics' pipeline and clinical trials that could further expand sales of Adcetris.

Metric

Q4 2016

Q4 2015

Year-Over-Year Change

Revenue

$105 million

$93 million

12.6%

Income from operations

($55.8 million)

($25.1 million)

N/A

Earnings per share

($0.39)

($0.18)

N/A

Data source: Seattle Genetics.

Image source: Getty Images.

Clay Siegall, Seattle Genetics' president and CEO, asked investors to look past 2017 guidance and see the bigger picture: "What is really important with Adcetris is not the sales we have now. What's really important is going toward the big items of [ECHELON-1] and [ECHELON-2], and you can even include ALCANZA in there."

On the delay of submitting the application for CTCL patients, Siegall didn't even want to call it that. "To me it's not a delay. To me it's taking advantage of an opportunity," he said. "I think we have a really good opportunity to end up with a bigger market if we can get a bigger label."

Management guided for Adcetris sales of $280 million to $300 million this year, which is 5.3% to 12.9% higher than last year's sales. Royalty revenue is expected to be in the $50 million to $55 million range, down from the $67.5 million in 2016, but last year included a $20 million milestone payment.

The difference between the bottom and top of guidance likely has to do with how many doctors prescribe Adcetris for CTCL off-label ahead of the FDA approval. But capturing those patients now versus next year isn't particularly important for Seattle Genetics' long-term value.

Brian Orelli has no position in any stocks mentioned. The Motley Fool recommends Seattle Genetics. The Motley Fool has a disclosure policy.

Dr. Orelli is a Senior Biotech Specialist. He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007.

Read the original:
Seattle Genetics Earnings: Waiting on ECHELON - Motley Fool

miRagen Therapeutics (MGEN) Completes Merger with Signal Genetics (SGNL) – StreetInsider.com

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Miragen Therapeutics, Inc. (Nasdaq: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of microRNA-targeted therapies, today announced the completion of its merger with Signal Genetics, Inc. (Nasdaq: SGNL) , effective February 13, 2017. Concurrent with the closing of the merger, miRagen received gross proceeds of $40.7 million in new equity investment from a combination of current and new miRagen investors, including Fidelity Management and Research Company, Brace Pharma Capital, Atlas Venture, Boulder Ventures, JAFCO Co., Ltd., MP Healthcare Venture Management, MRL Ventures (a venture fund of Merck, known as MSD outside the United States and Canada), Remeditex Ventures, and others. Together with pre-merger cash on miRagens balance sheet, the combined company has approximately $60 million in cash and short-term investments.

Upon completion of the merger today, Signal was renamed Miragen Therapeutics, Inc. The combined company will commence trading on The NASDAQ Capital Market under the symbol MGEN on February 14, 2017.

The completion of this merger marks a significant step forward for miRagen, our investors and potentially thousands of patients awaiting a therapeutic option for their conditions, said miRagen President and CEO William S. Marshall, Ph.D. The equity investment aligns the companys cash resources with our plan to advance the first two clinical programs into additional trials and to develop a compelling pipeline of targeted product candidates, each focused on patient populations with few clinical options. We believe these transactions will help us create a more focused and well financed organization as we build an exciting enterprise, an innovative culture and value for current and future stockholders.

Following the completion of the financing and merger, the combined company has approximately 21.3 million shares of common stock outstanding.

miRagens stockholders, including those who invested in the concurrent financing, received common stock, representing approximately 95.2% of the outstanding shares. Signals stockholders retained approximately 4.8% of the combined company.

The combined company will operate under the leadership of Dr. Marshall, and the board of directors of the combined company is comprised of seven members: Bruce Booth, John Creecy, Thomas Hughes, Kevin Koch, Kyle Lefkoff, Joseph Turner and Dr. Marshall.

Wedbush PacGrow acted as placement agent for miRagen in the financing.

Here is the original post:
miRagen Therapeutics (MGEN) Completes Merger with Signal Genetics (SGNL) - StreetInsider.com

Genetics of height: It may be too complex for scientists to crack the code – Genetic Literacy Project

[W]hen the human genome was sequenced, scientists like [Joel Hirschhorn, a geneticist at Boston Childrens Hospital and the Broad Institute] thought they could plumb that data to track all the height genes.

That effort started slowly. But now, Hirschhorn says, For height there are about 700 variants known to affect height, each of them usually with a pretty small effect on height, usually like a millimeter or less.

Even so, the traits [Hirschhorn] found only explain about a quarter of the inherited height factors. And, frustratingly, for most of those variants scientists have no idea what they actually do.

Hirschhorn and his colleagues are expanding their already massive study of 700,000 subjects. That approach has drawn skepticism from some scientists, who think its a waste of effort.

David Goldstein, a professor of genetics at Columbia University, says an expanded effort could ultimately implicate every gene in existence, and that hardly helps scientists narrow down the biological factors that contribute to height.

Its likely scientists will never be able to figure out what these hundreds of common variants do to influence height, Goldstein says. Instead, a much better strategy is [to look] for rare variants that pack a big punch.

[The study can be found here.]

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post:Genetics of Height is Way Complex, It Turns Out

See the article here:
Genetics of height: It may be too complex for scientists to crack the code - Genetic Literacy Project

Mutant maize offers key to understanding plant growth – Phys.Org

February 13, 2017 From left, normal and mutant maize plants. Credit: UC Riverside

How plant cells divide and how that contributes to plant growth has been one of the longstanding unsolved mysteries of cell biology. Two conflicting ideas have fueled the mystery.

The first idea is that cells divide merely to fill space in plant tissue, and therefore the orientation of the division is unimportant to growth. In other words, the contribution of individual cell behavior to overall growth isn't very important.

The second idea is that individual cells are the basic unit of life and their individual programs eventually build an organism. In other words, each new cell created contributes to proper patterning of the tissue. In this case, the orientation of each cell's division is critical for how the plant tissue is patterned and also impacts growth.

New findings by a University of California, Riverside-led team of researchers, lend support to the second idea, that the orientation of cell division is critical for overall plant growth. The work was just published in the journal Proceedings of the National Academy of Sciences.

The researchers, led by Carolyn Rasmussen, an assistant professor of plant cell biology at UC Riverside and Pablo Martinez, a graduate student working in Rasmussen's lab, together with Anding Luo and Anne Sylvester at University of Wyoming, were working with a maize mutant, called tangled1, with known defects in growth and division plane orientation of cells. Division plane orientation refers to the positioning of new cell walls during division.

They used time-lapse live cell imaging that represented hundreds of hours of maize, (commonly called corn in the United States), cells dividing. The time-lapse of imaging allowed them to characterize a previously unknown delay during cell division stages in the maize mutant. This study clarified the relationship between growth, timely division progression and proper division plane orientation.

This study suggests that delays during division do not necessarily cause growth defects, but that improper placement of new cell walls together with delays during division causes growth defects. Therefore, division plane orientation is a critical but potentially indirect factor for growth.

The findings might have long-term implications for increasing agricultural production. For example, during the Green Revolution of the mid-20th century, researchers developed short-stature, or dwarf, wheat and rice varieties that led to higher yields and are credited with saving over a billion people from starvation. Understanding the molecular mechanisms of plant growth might contribute in the long-term to developing more suitable short-stature maize varieties.

The paper is called "Proper division plane orientation and mitotic progression together allow normal growth of maize."

Explore further: How plant cells regulate growth shown for the first time

More information: Proper division plane orientation and mitotic progression together allow normal growth of maize, PNAS, http://www.pnas.org/cgi/doi/10.1073/pnas.1619252114

Researchers have managed to show how the cells in a plant, a multicellular organism, determine their size and regulate their growth over time. The findings overturn previous theories in the field and are potentially significant ...

Among bacteria, the spirochetes are characterized by their spiral shape and remarkable lengthas much 50 times longer than most other bacteria. This can make cell elongation and division a laborious process. One of those ...

Cell division is a fundamental process of life, producing two cells from one single cell at each cell division. During animal development, a fertilized egg divides many times, increasing the number of cells, which are precisely ...

Researchers at the Institute of Molecular Biotechnology in Vienna have unravelled how a tiny microRNA molecule controls growth and differentiation of brain cells.

Modern genome sequencing methods used to measure the efficiency of synthesis of individual protein during cell division has found that the enzymes that make lipids and membranes were synthesized at much greater efficiency ...

A study conducted by a research team led by Michel Cayouette, Full IRCM Research Professor and Director of the Cellular Neurobiology research unit, in collaboration with a team led by Stphane Angers, Associate Professor ...

A new report from the Stowers Institute for Medical Research chronicles the embryonic origins of planaria, providing new insight into the animal's remarkable regenerative abilities.

How plant cells divide and how that contributes to plant growth has been one of the longstanding unsolved mysteries of cell biology. Two conflicting ideas have fueled the mystery.

Watching the smooth movement generated by hundreds of fish as they swim in unison is truly mesmerising. But it's not only its sheer beauty that makes it so hard to look away, for scientists, it's also the fact that its emergence ...

Recent evidence demonstrates that the origins of photosynthesis can be found in deep sea hydrothermal vents, where microbes evolved to obtain energy from ejected hydrogen sulfide and methane gases. These microbes are capable ...

A new study of songbird dehydration and survival risk during heat waves in the United States desert Southwest suggests that some birds are at risk of lethal dehydration and mass die-offs when water is scarce, and the risk ...

Scientists have discovered a new protein that likely will advance the search for new natural antibiotics, according to a study by Texas A&M AgriLife Research published Feb. 13 in the journal Nature Microbiology.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Read this article:
Mutant maize offers key to understanding plant growth - Phys.Org

Macabre event Anatomy Lab LIVE is really happening in Cornwall on April Fool’s Day – Cornwall Live

Comments(0)

It may seem like an unbelievable event and be happening on April Fool's Day but Anatomy Lab LIVE is definitely real and is definitely coming to Cornwall.

We announced last month that the intriguing tour where you have a two-course dinner before watching a "body" being dissected was coming to Cornwall and now the date and venue has been announced.

The sell-out tour Anatomy Lab LIVE will perform a live dissection of VIVIT the world's only semi-synthetic human cadaver for audiences this April.

Anatomist Samuel Piri will perform the dissection procedure to showcase health and disease on real internal organs at this unforgettable event.

VIVIT is a specially constructed synthetic human cadaver that houses real organs. During the procedure Samuel will dissect VIVIT to reveal the inside of the head and jaw demonstrating the brain and spinal cord.

READ MORE: New live show which lets you eat dinner before seeing a body dissected

Following this Samuel will open the thoracic cavity to show the trachea, lungs and heart followed by the abdominal cavity revealing the stomach, liver, gall bladder, intestines, kidneys and bladder.

All of VIVIT's organs are of swine origin due to their anatomical similarities with humans.

READ MORE: Planetariums, pirates and playfests - 23 great things to do with the kids in Cornwall this half-term

Live on stage Samuel will compare the human body in its healthy form to anatomical samples damaged by excessive alcohol consumption and smoking.

Audiences will have chance to put their questions to Samuel and to leading medics accompanying him on stage. Following the procedure the samples will be prepped for handling by those in the audience who wish to further examine the specimens.

The Cornwall tour event will be held at St Mellion International Resort on Saturday, April 1. The event begins at 6pm finishing at 11.45pm. Tickets include a two-course sit down meal before the procedure begins. Tickets are priced 60 per person or a group ticket that admits 6 is 300. All ticket holders must be over 16.

For more information visit http://www.inspiretoaspireevents.co.uk

WHAT'S ON IN CORNWALL

Read this article:
Macabre event Anatomy Lab LIVE is really happening in Cornwall on April Fool's Day - Cornwall Live